Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spatially fractionated radiation therapy (SFRT), sometimes referred to as spatial dose fractionation, is an approach in radiation oncology in which the radiation dose is intentionally delivered to the tumor in a non-uniform, spatially heterogeneous pattern, often using GRID-blocks, multileaf collimators, or lattice arrangements, creating regions of high-dose (“peaks”) alternating with low-dose (“valleys”) zones within the targeted tissue. This design distinguishes SFRT from conventional homogeneous dosing and is used to treat large or radioresistant tumors, aiming to spare surrounding normal tissues, stimulate anti-tumor immune responses, and exploit radiobiological phenomena such as the bystander effect and vascular disruption. SFRT is a technique and not a discrete molecular target[1][4][3][2]. To clarify: Spatial dose fractionation/SFRT is a treatment modality/technique and should not be considered a druggable molecular or cellular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spatially fractionated radiation therapy (SFRT).